LONDON (Alliance News) -The best performing investment fund in November in price was Dolphin Capital after the sale of one of its properties strengthened its balance sheets.
However the majority of November's other winners were propelled by the election of Donald Trump as US president. Jupiter US Smaller Companies and JPMorgan Smaller Companies both benefited from positive expectations for the US economy, while International Biotechnology and Biotech Growth were boosted as the threat of stricter healthcare regulation under Hillary Clinton disappeared.
The losers from the election result included Golden Prospect and UIL as a more confident investment mood hit the price of gold. Emerging market funds were hit by fears of a Trump-instigated trade war, especially Latin American funds JPMorgan Brazil, BlackRockLatin American and Aberdeen Latin American.
Indian funds were also down in the month as the government's withdrawal of bank notes to combat corruption spooked investors, hurting India Capital, New India and JPMorgan India.
The following were the best and worst performing London-listed investment companies in November:
Best performing funds in price terms
| % change | |
| Dolphin Capital | 33.3 |
| Polo Resources | 17.5 |
| Lindsell Train | 14.4 |
| Biotech Growth | 12.4 |
| Alpha Real Trust | 10.9 |
| BH Macro (GBP) | 10.8 |
| F&C Commercial Property | 10.1 |
| Industrial Multi Property | 9.9 |
| Polar Capital Global Financials | 9.6 |
| JPMorgan US Smaller Companies | 9.1 |
Worst performing funds in price terms
| % change | |
| Golden Prospect Prcious Metals | -24.9 |
| UIL | -16.9 |
| Aberdeen Latin American Income | -15.5 |
| JPMorgan Brazil | -15.4 |
| Green REIT | -15.2 |
| BlackRock Latin American | -14.0 |
| Pacific Horizon | -14.0 |
| JPMorgan Indian | -12.7 |
| India Capital Growth | -12.6 |
| Schroder European Real Estate | -12.5 |
Best performing funds in NAV terms
| % change | |
Kennedy Wilson Europe | 7.4 |
| Rights & Issues | 7.2 |
| Jupiter US Smaller Companies | 6.7 |
| Gabellie Value Plus+ | 6.5 |
| JPMorgan US Smaller Companies | 6.5 |
| Polar Capital Global Financials | 6.3 |
| International Biotechnology | 6.1 |
| Chelverton Small Companies Dividend | 6.0 |
| Biotech Growth | 5.5 |
| BH Macro (GBP) | 5.4 |
Worst performing funds in NAV terms
| % change | |
| Golden Prospect Precious Metals | -18.6 |
| JPMorgan Brazil | -16.2 |
| BlackRock Latin American | -13.9 |
| Candover | -13.6 |
| JPMorgan Indian | -13.5 |
| Aberdeen Latin American Income | -13.5 |
| Aseana Properties | -12.1 |
| Prospect Japan | -11.6 |
| India Capital Growth | -10.8 |
| New India | -10.1 |
Source: QuotedData. Full details at www.quoteddata.com
Copyright 2016 Alliance News Limited. All Rights Reserved
Jpmorg.us (JUSC)
JPMorgan Indian (JII)
Int.biotech. (IBT)
Blackrock Lat A (BRLA)
Pacific Horizon (PHI)
Polar Cap Gbl (PCFT)
Biotech Gwth (BIOG)
BH Macro GBP (BHMG)
Chelvertn Uk (SDV)
India Cap (IGC)
Lindsell Train (LTI)
Util (UTL)
Alpha Real (ARTL)
Dci Advisors (DCI)
Schroder Eur.r (SERE)
Aseana Prop. (ASPL)